Quality-of-life advancements in the treatment of adolescent and pediatric patients with gynecologic malignancies

Abstract

Adolescent and pediatric gynecologic oncology patients represent a subgroup of patients afflicted with malignancies in which significant improvement has been noted. In this article we discuss the specific factors which led to improvement in survival of these patients, but most importantly, how these improvements paralleled the improvements in quality-of-life issues for patients who only two decades ago were sentenced to a poor prognosis, a dismal outlook, and a miserable limited human existence.